Inbal Zafir-lavie ^Leaders

Inbal Zafir-Lavie is currently the CEO and Co-Founder of Gina Life, where she leads innovative initiatives focused on womens health. Previously, she served as the CEO and Co-Founder of Nevia Bio, a pioneering company developing a machine learning platform for the detection of womens diseases, including ovarian cancer. Inbal has also held significant roles as a Senior Scientist at Merck Group and Aevi Genomic Medicine, where she contributed to advanced research in immunology, cancer therapies, and regulatory science. She is an Advisory Board Member at Arizona State University and was recognized as a Cohort Finalist and platinum prize winner at MassChallenge Israel. Inbal holds a PhD in Molecular Immunology from the Technion - Israel Institute of Technology, where she graduated Cum Laude, and has published extensively in reputable journals. Her expertise is further underscored by her patent for genetically modified microorganisms, showcasing her commitment to advancing medical science.